Tech Company Financing Transactions
X-37 Funding Round
Data Collective, Alpha Intelligence Capital and Hemi Ventures participated in a $14.5 million Series A venture round for X-37. This venture round was announced on 11/15/2019.
Transaction Overview
Company Name
Announced On
11/15/2019
Transaction Type
Venture Equity
Amount
$14,500,000
Round
Series A
Investors
Proceeds Purpose
The Series A funding will be used to expand the number of drug development programs at X-37 and to advance identified drug leads through laboratory and preclinical testing, with the goal of beginning human clinical trials by 2022.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Oyster Point Blvd. 202
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Collier
VP - General Counsel
Anie Roche
Browse more venture capital transactions:
Prev: 11/15/2019: Let's Do This venture capital transaction
Next: 11/15/2019: Enlitic venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs